Knowledge Base
White Papers
FEATURED WHITE PAPER
|
|
Direct-to-Patient (DtP)Clinical Trials
|
|
|
RTSM Best Practices
Best Practices for Randomization and Trial Supply Management (RTSM)
Guidelines for Sponsor IRT Strategy –Study Start-Up, Maintenance and Close-Out
User Acceptance Testing and RTSM System Validation
Demonstrating Joint Responsibility (Vendor and Sponsor) for Ensuring RTSM Validation in a Highly-Regulated Environment
Should Technology Vendors Sit at the Sponsor Table?
The Power of RTSM Problem Solvers on Your Team
New Paradigm for RTSM Customer Support
Pillars of Excellence to Redefine the Customer Experience
Modern Technology and Agile RTSM
Disrupting Study Start-Up
How Agile RTSM Software Development Accelerates the Clinical Trial Timeline
Faster Study Start-Up
How Natural Language Processing (NLP) is a Game Changer in Clinical Research
Modern Technologies in Clinical Trials
Demystifying the use of Innovative RTSMs in a Highly-Regulated Environment
Breaking the Mold in Clinical Systems Integrations
Leveraging Modern Technology to Seamlessly Integrate with (any) other Platforms
Clinical Supply
Clinical Supply Planning Optimization
Addressing Gaps in People, Process and Technology to Drive Supply Chain Efficiencies
Site Forecasting – Enabled by Confidence Dials
Informing Forecasting and Resupply Decisions Based on Business Needs Rather than Complex Calculations
Investigator Sponsored Trials (IST) Supply Chain Optimization
Leveraging RTSM/IRT Systems to Avoid Wasted Supply, Enable Drug Pooling and Accurately Project Demand
Direct-to-Patient
(DtP) Clinical
Trials
Leveraging Modern RTSM/IRT Systems to Overcome Supply Challenges with Direct-to-Patient Trials
